Zhejiang Hisun Pharmaceutical Co Ltd (shse:600267) Share Price

Company Profile

Business description
Zhejiang Hisun Pharmaceutical Co Ltd is a China-based pharmaceutical company. It is focused on the research, development, and distribution of pharmaceuticals. It produces and supplies antibiotics and anticancer drugs. The company's research channels cover indications like anticancer, cardiovascular, anti-infective, anti-parasitic, immunosuppressant and others. Its product portfolio includes active pharmaceutical ingredients like Anastrozole, Docetaxel, Methotrexate, and others and finished dosages such as letrozole tablets, anastrozole tablets, injection mitomycin, and others.
Contact
No. 46 Waisha Road
Jiaojiang District
Zhejiang Province
Taizhou318000
CHN
T: +86 4001180618
http://www.hisunpharm.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
7,994

Recommended

Shares screen as undervalued after prolonged decline.

Roy Van Keulen | 09 February 2026

With higher-than-expected revenue expectations and a raised fair value estimate, here’s what we think of Palantir stock.

Mark Giarelli | 09 February 2026

Our view after merger talks end.

Jon Mills, CFA | 09 February 2026

Index	Last price	Change	% Change
All Ordinaries	9,166.80	7.60	-0.08%
CAC 40	8,323.28	49.44	0.60%
DAX 40	25,014.87	293.41	1.19%
Dow JONES (US)	50,135.87	20.20	0.04%
FTSE 100	10,386.23	16.48	0.16%
HKSE	27,027.16	467.21	1.76%
NASDAQ	23,238.67	207.46	0.90%
Nikkei 225	57,213.56	849.62	1.51%
NZX 50 Index	13,498.02	51.65	0.38%
S&P 500	6,964.82	32.52	0.47%
S&P/ASX 200	8,902.20	9.40	-0.11%
SSE Composite Index	4,123.09	57.51	1.41%